Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis - Trial NCT06284200
Access comprehensive clinical trial information for NCT06284200 through Pure Global AI's free database. This phase not specified trial is sponsored by Kayseri City Hospital and is currently Recruiting. The study focuses on Sarcopenia. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Kayseri City Hospital
Timeline & Enrollment
N/A
Jun 23, 2023
Jun 23, 2024
Primary Outcome
Evaluation of Muscle Mass,Evaluation of Muscle Strength,Evaluation of Muscle Performance
Summary
introduction: In this study, the presence of sarcopenia in cases with early rheumatoid
 arthritis and established rheumatoid arthritis will be compared.
 
 Materials and Method: According to the power analysis, 24 patients with early rheumatoid
 arthritis and 24 patients with established rheumatoid arthritis who meet the 2010 American
 College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR)
 rheumatoid arthritis (RA) classification criteria will be included in the study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06284200
Non-Device Trial